US 11,684,701 B2
Operating room coating applicator and method
Frank Richard Cichocki, Easton, PA (US); and Duan Li Ou, Warren, NJ (US)
Assigned to Ethicon, Inc., Raritan, NJ (US)
Filed by Ethicon, Inc., Somerville, NJ (US)
Filed on Nov. 27, 2019, as Appl. No. 16/697,227.
Claims priority of provisional application 62/773,102, filed on Nov. 29, 2018.
Prior Publication US 2020/0171528 A1, Jun. 4, 2020
Int. Cl. A61L 27/54 (2006.01); A61L 2/03 (2006.01); A61L 2/07 (2006.01); A61L 2/20 (2006.01); A61L 2/26 (2006.01); A61L 17/00 (2006.01); B05B 7/16 (2006.01); B05B 15/00 (2018.01); A61L 17/14 (2006.01); C09D 7/20 (2018.01); C09D 7/62 (2018.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); C09D 5/14 (2006.01); C09D 183/04 (2006.01); C10M 107/50 (2006.01); B05B 12/08 (2006.01); B05B 17/06 (2006.01); B05D 1/02 (2006.01); B05D 3/04 (2006.01); C10N 40/00 (2006.01); C10N 30/16 (2006.01); C10N 50/08 (2006.01); A61M 11/00 (2006.01)
CPC A61L 27/54 (2013.01) [A61L 2/03 (2013.01); A61L 2/07 (2013.01); A61L 2/20 (2013.01); A61L 2/26 (2013.01); A61L 17/005 (2013.01); A61L 17/145 (2013.01); A61L 31/10 (2013.01); A61L 31/14 (2013.01); A61L 31/16 (2013.01); B05B 7/1606 (2013.01); B05B 7/1686 (2013.01); B05B 12/081 (2013.01); B05B 15/00 (2013.01); B05B 17/0615 (2013.01); B05D 1/02 (2013.01); B05D 3/0493 (2013.01); C09D 5/14 (2013.01); C09D 7/20 (2018.01); C09D 7/62 (2018.01); C09D 183/04 (2013.01); C10M 107/50 (2013.01); A61L 2202/181 (2013.01); A61L 2202/182 (2013.01); A61L 2300/202 (2013.01); A61L 2300/404 (2013.01); A61L 2300/606 (2013.01); A61L 2400/10 (2013.01); A61L 2420/02 (2013.01); A61L 2420/04 (2013.01); A61L 2420/06 (2013.01); A61M 11/005 (2013.01); C10M 2229/0445 (2013.01); C10N 2030/16 (2013.01); C10N 2040/50 (2020.05); C10N 2050/08 (2013.01)] 23 Claims
OG exemplary drawing
 
1. A coating applicator operable to apply a coating of a therapeutic agent upon an object to be coated, comprising:
an openable and sealable device compartment having a rigid wall;
a therapeutic agent positioned in communication with the device compartment;
an atomizer operable to atomize the therapeutic agent, wherein the atomizer comprises an ultrasonic nebulizer and/or a jet nebulizer and/or a vibrating mesh nebulizer and/or a pressurized spray nozzle nebulizer and/or a vibrated frit nebulizer and/or a thermally driven, wick-based aerosol generator and/or a heated capillary aerosol generator and/or a vaporizer;
a source of vacuum in communication with the device compartment;
a drier, the drier comprising an arrangement to operate the source of vacuum for a time sufficient to promote drying of the deposited therapeutic agent;
a base comprising a first connection operable to communicate the source of vacuum with the device compartment and a second connection operable to communicate a source of electrical power to the device compartment for operating the atomizer; and
a vacuum lid removably and sealably connectable to the base, whereby a sealed space is established about the device compartment,
wherein the device compartment comprises an openable box configured for placement within the sealed space, the openable box comprising:
a support for the object to be coated;
a first receiver for receiving the first connection of the base; and
a second receiver for receiving the second connection of the base.